Inventor · disambiguated record
Mario Grugni
Also filed as: GRUGNI MARIO
12 granted patents·28 pending applications·186 citations·filing 1995–2010
91Inventor score
Files withSMITHKLINE BEECHAM SPA9CELL THERAPEUTICS INC4GLAXOSMITHKLINE SPA3SMITHKLINE BEECHAM FARMA3GLAXOSMITHKLINE S A S2
Top patents by PatentIndex Score
40 records- 0190US5811553AQuinoline derivatives(2)SMITHKLINE BEECHAM FARMA·Filed 1995·Granted Sep 22, 1998·68 cites·2 claims
- 0287US7482458B2Quinoline derivativesSMITHKLINE BEECHAM FARMA·Filed 2006·Granted Jan 27, 2009·8 cites·1 claims
- 0381US6743804B2Quinoline derivatives as NK3 antagonistsSMITHKLINE BEECHAM SPA·Filed 2002·Granted Jun 1, 2004·11 cites·1 claims
- 0478US6277862B1Quinoline derivativesSMITHKLINE BEECHAM SPA·Filed 1996·Granted Aug 21, 2001·47 cites·29 claims
- 0572US6780875B2Quinoline-4-carboxamide derivatives as NK-3 and NK-2 receptor antagonistsSMITHKLINE BEECHAM SPA·Filed 2003·Granted Aug 24, 2004·6 cites·6 claims
- 0670US6608083B1Quinoline derivatives(2)SMITHKLINE BEECHAM FARMA·Filed 1995·Granted Aug 19, 2003·21 cites·54 claims
- 0768US6969724B2CompoundsSMITHKLINE BEECHAM SPA·Filed 2002·Granted Nov 29, 2005·5 cites·6 claims
- 0865US8329853B2Process for the preparation of poly-α-glutamic acid and derivatives thereofMCKENNON MARC·Filed 2010·Granted Dec 11, 2012·2 cites·30 claims
- 0963US2007197546A1Quinoline-4-carboxamide as nk-2 and nk-3 receptor antagonistsSMITHKLINE BEECHAM SPA ITALY·Filed 2007·Application pending·0 cites
- 1061US7115633B2Benzosuberonylpiperdine compounds as analgesicsGLAXOSMITHKLINE SPA·Filed 2001·Granted Oct 3, 2006·2 cites·29 claims
- 1160US2006205735A1Quinoline-4-carboxamide as NK-2 and NK-3 receptor antagonistsMARIA GLARDINA GIUSEPPE A·Filed 2006·Application pending·0 cites
- 1260US2005096316A1Quinoline derivatives(2)Filed 2004·Application pending·0 cites
- 1359US6355654B1Salts of quinoline derivatives as NK3 antagonistsSMITHKLINE BEECHAM SPA·Filed 1996·Granted Mar 12, 2002·11 cites·6 claims
- 1457US2005159428A1Quinoline-4-carboxamide derivatives asNK-2 and NK-3 receptor antagonistsSMITHKLINE BEECHAM SPA ITALY·Filed 2005·Application pending·0 cites
- 1556US2005070574A1Novel compoundsGLAXOSMITHKLINE SPA AND LABORA·Filed 2004·Application pending·0 cites
- 1655US2006161004A1Novel compoundsGLAXOSMITHKLINE LAB SAS·Filed 2006·Application pending·0 cites
- 1753US2004116469A1Quinoline-4-carboxamide derivatives as NK-2 and NK-3 receptor antagonistsSMITHKLINE BEECHAM SPA·Filed 2003·Application pending·0 cites
- 1852US2006235026A1Quinoline-4-Carboxamide Derivatives as NK-3 and NK-2 Receptor AntagonistsGLAXOSMITHKLINE S A S·Filed 2006·Application pending·0 cites
- 1952US2008255099A1Use of Diketodithiopiperazine Antibiotics for the Preparation of Antiangiogenic Pharmaceutical CompositionsCELL THERAPEUTICS INC·Filed 2005·Application pending·0 cites
- 2051US2007015766A1Quinoline Derivatives as NK-3 and NK-2 AntagonistsGLAXOSMITHKLINE S A S·Filed 2006·Application pending·0 cites
- 2151US2003236281A1Quinoline derivatives(2)Filed 2001·Application pending·0 cites
- 2250US2002156097A1Salts of quinoline derivatives as NK3 antagonistsSMITHKLINE BEECHAM SPA·Filed 2002·Application pending·0 cites
- 2349US2006122387A1Derivatives of chromen-2-one as inhibitors of vegf production in mammalian cellsCTI EUROP S R L·Filed 2003·Application pending·0 cites
- 2449US2003004183A1Quinoline-4-carboxamide derivatives as NK-2 and NK-3 receptor antagonistsFiled 2002·Application pending·0 cites
- 2549US2004102633A1Novel compoundsFiled 2001·Application pending·0 cites
- 2648US2008051603A1Process for the preparation of poly-alpha-glutamic acid and derivatives thereofCELL THERAPEUTICS INC·Filed 2007·Application pending·0 cites
- 2747US2001012846A1Quinoline-4-carboxamide derivatives as NK-2 and NK-3 receptor antagonistsFiled 2000·Application pending·0 cites
- 2846US2013018096A1Platinum complex with antitumor activityCELL THERAPEUTICS INC·Filed 2009·Application pending·0 cites
- 2944US6613770B1Quinoline derivatives as NK-2 and NK-3 receptor ligandsSMITHKLINE BEECHAM SPA·Filed 1999·Granted Sep 2, 2003·5 cites·10 claims
- 3044US2004077658A1Quinoline-4-carboxamide derivatives as nk-3 and nk-2 receptor antagonistsFiled 2001·Application pending·0 cites
- 3144US2004082589A1Quinoline derivatives as nk-3 and nk-2 antagonistsFiled 2001·Application pending·0 cites
- 3244US2005182093A1Novel compoundsGLAXOSMITHKLINE SPA·Filed 2005·Application pending·0 cites
- 3343US2006223819A1Quinoline Derivatives as NK-3 AntagonistsGLAXOSMITHKLINE SPA·Filed 2006·Application pending·0 cites
- 3442US2008261980A1Use of Thiazolidinone Derivatives as Antiangiogenic AgentsCELL THERAPEUTICS INC·Filed 2005·Application pending·0 cites
- 3540US2002068827A1Quinoline-4-carboxamide derivatives, their preparation and their use as neurokinin 3 ( NK-3 ) - and neurokinin 2 ( NK-3 ) receptor antagonistsSMITHKLINE BEECHAM SPA·Filed 2001·Application pending·0 cites
- 3640US2004152730A1Novel compoundsFiled 2002·Application pending·0 cites
- 3739US2004097518A1Quinoline derivatives as nk-3 antagonistsFiled 2001·Application pending·0 cites
- 3837US2005209195A1Indolinone derivativesCELL THERAPEUTICS EUROP S R I·Filed 2005·Application pending·0 cites
- 3933US8426625B2Bis-platinum complexes with antitumor activityBERNAREGGI ALBERTO·Filed 2006·Granted Apr 23, 2013·0 cites·17 claims
- 4033US2009036441A1Indole Derivatives With Antitumor ActivityCELL THERAPEUTICS EUROPE SRL·Filed 2005·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Mario Grugni files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →